# Home With TablO outcoMEs (HOME) Registry

> **NCT04526301** · — · UNKNOWN · sponsor: **Outset Medical** · enrollment: 500 (estimated)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DEVICE:** Tablo Hemodialysis System

## Key facts

- **NCT ID:** NCT04526301
- **Lead sponsor:** Outset Medical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-14
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2022-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04526301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04526301, "Home With TablO outcoMEs (HOME) Registry". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04526301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*